Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
- PMID: 22891207
- PMCID: PMC3470615
- DOI: 10.1503/cmaj.121270
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
Comment on
-
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13. CMAJ. 2012. PMID: 22891208 Free PMC article.
References
-
- Björnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006;38:33–8 - PubMed
-
- Motola D, Vargiu A, Leone R, et al. Hepatic adverse drug reactions: a case–noncase study in Italy. Eur J Clin Pharmacol 2007; 63:73–9 - PubMed
-
- Van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009;32:359–78 - PubMed
-
- Brinker AD, Wassel RT, Lyndly J, et al. Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases. Hepatology 2009;49:250–7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical